Document:

Form of Indemnity Agreement

 Exhibit 10.14 
  
 INDEMNIFICATION AGREEMENT 
  
 THIS INDEMNIFICATION AGREEMENT is made and entered into as of the         th day of
            , 2004 (the “Agreement”), by and between Axesstel, Inc., a Nevada corporation (the “Company”), and
                                 (the “Indemnitee”), with reference to the
following facts: 
  
 A. The Company desires the benefits of having
Indemnitee serve as an officer and/or director secure in the knowledge that any expenses, liability and/or losses incurred by him or her in his or her good faith service to the Company will be borne by the Company or its successors and assigns.

  
 B. Indemnitee is willing to serve in his or her position with
the Company only on the condition that he or she be indemnified for such expenses, liability and/or losses. 
  
 C. The Company and Indemnitee recognize the increasing difficulty in obtaining liability insurance for directors, officers and agents of a corporation at
reasonable cost. 
  
 D. The Company and Indemnitee recognize that
there has been an increase in litigation against corporate directors, officers and agents. 
  
 E. The Company’s Bylaws, as amended and restated, provide for the indemnification of officers and directors, and further provide that the rights of indemnification provided in the Bylaws are not exclusive of
other rights a person may have, including rights under agreements. 
  
 F. Section 78.751 of the Nevada General Corporation Law permits a corporation organized under Nevada law to enter into an agreements with respect to indemnification. 
  
 NOW, THEREFORE, the parties hereby agree as follows: 
  

	 	1.	Definitions. For purposes of this Agreement: 

  
         1.1 “Agent” shall mean any person who (a) is or was a director, officer, employee or
agent of the Company, or a subsidiary of the Company whether serving in such capacity or as a director, officer, employee, agent, fiduciary or other official of another corporation, joint venture, trust or other enterprise at the request of, for the
convenience of, or to represent the interests of the Company or a subsidiary of the Company or (b) was a director, officer, employee or agent of Axesstel, Inc., a California corporation (the “Predecessor Corporation”), whether serving in
such capacity or as a director, officer, employee, agent, fiduciary or other official of another corporation, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of such Predecessor
Corporation. 
  
         1.2 “Change of Control” shall mean the occurrence of any of the following events after the date of this Agreement: 
  
               (a) A change in the composition of the board of directors of the Company (the “Board”), as a result of which fewer than two-thirds of the
incumbent directors are 
  

 1 

 directors who either (a) had been directors of the Company 24 months prior to such change or (b) were elected, or
nominated for election, to the Board with the affirmative votes of at least a majority of the directors who had been directors of the Company 24 months prior to such change and who were still in office at the time of the election or nomination; or

  
               (b) Any “person” (as such term is used in sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (the “Exchange Act”),
as amended), through the acquisition or aggregation of securities is or becomes the beneficial owner, directly or indirectly, of securities of the Company representing 50 percent or more of the combined voting power of the Company’s then
outstanding securities ordinarily (and apart from rights accruing under special circumstances) having the right to vote at elections of directors (the “Capital Stock”); provided, however, that any change in ownership of the Company’s
securities by any person resulting solely from a reduction in the aggregate number of outstanding shares of Capital Stock, and any decrease thereafter in such person’s ownership of securities, shall be disregarded until such person increases in
any manner, directly or indirectly, such person’s beneficial ownership of any securities of the Company. Notwithstanding the foregoing, the ownership of Capital Stock by Mike Hyuang Pyo Kwon or by any corporation, partnership, trust or other
entity where Mr. Kwon retains sole or shared voting control over such Capital Stock, shall not be deemed a Change of Control. 
  
         1.3 “Disinterested Director” shall mean a director of the Company who is not and was not
a party to the Proceeding in respect of which indemnification is being sought by Indemnitee. 
  
         1.4 “Expenses” shall be broadly construed and shall include, without limitation, (a) all direct and indirect costs incurred, paid or accrued, (b) all
attorneys’ fees, retainers, court costs, transcripts, fees of experts, witness fees, travel expenses, food and lodging expenses while traveling, duplicating costs, printing and binding costs, telephone charges, postage, delivery service,
freight or other transportation fees and expenses, (c) all other disbursements and out-of-pocket expenses, (d) amounts paid in settlement, to the extent not prohibited by Nevada Law, and (e) reasonable compensation for time spent by Indemnitee for
which he or she is otherwise not compensated by the Company or any third party, actually and reasonably incurred in connection with or arising out of a Proceeding, including a Proceeding by Indemnitee to establish or enforce a right to
indemnification under this Agreement, applicable law or otherwise. 
  
         1.5 “Independent Counsel” shall mean a law firm or a member of a law firm that neither is presently nor in the past five years has been retained to represent: (a) the Company,
an affiliate of the Company or Indemnitee in any matter material to either party or (b) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel”
shall not include any person who, under the applicable standards of professional conduct then prevailing would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s right to
indemnification under this Agreement. 
  
         1.6 “Liabilities” shall mean liabilities of any type whatsoever, including, but not limited to, judgments or fines, ERISA or other excise taxes and penalties, and amounts paid

  

 2 

 in settlement (including all interest, assessments or other charges paid or payable in connection with any of the
foregoing) actually and reasonably incurred by Indemnitee in connection with a Proceeding. 
  
         1.7 “Nevada Law” means the Nevada General Corporation Law, as amended and in effect from time to time or any successor or other statutes of Nevada
having similar import and effect. 
  
         1.8 “Proceeding” shall mean any pending, threatened or completed action, hearing, suit or any other proceeding, whether civil, criminal, arbitrative, administrative,
investigative or any alternative dispute resolution mechanism, including without limitation any such Proceeding brought by or in the right of the Company. 
  
 2. Employment Rights and Duties. Subject to any other obligations imposed on either of the parties by contract or by law, and with
the understanding that this Agreement is not intended to confer employment rights on either party which they did not possess on the date of its execution, Indemnitee agrees to serve as a director or officer so long as he or she is duly appointed or
elected and qualified in accordance with the applicable provisions of the Articles of Incorporation (the “Articles”) and Bylaws (the “Bylaws”) of the Company or any subsidiary of the Company and until such time as he or she
resigns or fails to stand for election or until his or her employment terminates. Indemnitee may from time to time also perform other services at the request, or for the convenience of, or otherwise benefiting the Company. Indemnitee may at any time
and for any reason resign or be removed from such position (subject to any other contractual obligation or other obligation imposed by operation of law), in which event the Company shall have no obligation under this Agreement to continue Indemnitee
in any such position. 
  
         2.1 Directors’ and Officers’ Insurance.  
  
               (a) The Company hereby covenants and agrees that, so long as
Indemnitee shall continue to serve as a director or officer of the Company and thereafter so long as Indemnitee shall be subject to any possible Proceeding, the Company, subject to Section 2.1(c), shall maintain directors’ and officers’
insurance in full force and effect. 
  
               (b) In all policies of directors’ and officers’ insurance, Indemnitee shall be named as an insured in such a manner as to provide
Indemnitee the same rights and benefits, subject to the same limitations, as are accorded to the Company’s directors or officers most favorably insured by such policy. 
  
               (c) The Company shall have no
obligation to maintain directors’ and officers’ insurance if the Company determines in good faith that such insurance is not reasonably available, the premium costs for such insurance are disproportionate to the amount of coverage
provided, or the coverage provided by such insurance is limited by exclusions so as to provide an insufficient benefit. 
  
               (d) If, at the time of the receipt by the Company of a notice
of a “Claim” as that term or any similar term is defined under any policy of directors’ and officers’ liability insurance maintained by the Company, the Company shall give prompt notice of the 
  

 3 

 commencement of such Claim to the insurer(s) in accordance with the procedures set forth in the respective policies. The
Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Claim in accordance with the terms of such policies. 
  
 3. Indemnification. The Company shall indemnify
Indemnitee to the fullest extent authorized or permitted by Nevada Law in effect on the date hereof, and as Nevada Law may from time to time be amended (but, in the case of any such amendment, only to the extent such amendment permits the Company to
provide broader indemnification rights than Nevada Law permitted the Company to provide before such amendment). Without in any way diminishing the scope of the indemnification provided by this Section 3, the Company shall indemnify Indemnitee if and
whenever he or she is or was a witness, party or is threatened to be made a witness or a party to any Proceeding, by reason of the fact that he or she is or was an Agent or by reason of anything done or not done, or alleged to have been done or not
done, by him or her in such capacity, against all Expenses and Liabilities actually and reasonably incurred by Indemnitee or on his or her behalf in connection with the investigation, defense, settlement or appeal of such Proceeding. In addition to,
and not as a limitation of, the foregoing, the rights of indemnification of Indemnitee provided under this Agreement shall include those rights set forth in Sections 4, 5 and 6 below. 
  
 4. Payment of Expenses. 
  
         4.1 All Expenses incurred by or on behalf of Indemnitee shall be
advanced by the Company to Indemnitee within 20 days after the receipt by the Company of a written request for such advance which may be made from time to time, whether prior to or after final disposition of a Proceeding (unless there has been a
final determination by a court of competent jurisdiction that Indemnitee is not entitled to be indemnified for such Expenses). Indemnitee’s entitlement to advancement of Expenses shall include those incurred in connection with any Proceeding by
Indemnitee seeking a determination, an adjudication or an award in arbitration pursuant to this Agreement. The requests shall reasonably evidence the Expenses incurred by Indemnitee in connection therewith. Indemnitee hereby undertakes to repay the
amounts advanced if it shall ultimately be determined that Indemnitee is not entitled to be indemnified pursuant to the terms of this Agreement. 
  
         4.2 Notwithstanding any other provision in this Agreement, to the extent that Indemnitee has been
successful on the merits or otherwise in defense of any Proceeding, Indemnitee shall be indemnified against all Expenses actually and reasonably incurred by Indemnitee in connection therewith. 
  
 5. Procedure for Determination of Entitlement to
Indemnification. 
  
         5.1 Whenever Indemnitee believes that he or she is entitled to indemnification pursuant to this Agreement, Indemnitee shall submit a written request for indemnification (the
“Indemnification Request”) to the Company to the attention of the Chief Executive Officer with a copy to the Corporate Secretary. This request shall include documentation or information which is necessary for the determination of
entitlement to indemnification and which is reasonably available to Indemnitee. Determination of Indemnitee’s entitlement to 
  

 4 

 indemnification shall be made no later than 60 days after receipt of the Indemnification Request. The Chief Executive
Officer or the Secretary shall, promptly upon receipt of Indemnitee’s request for indemnification, advise the Board in writing that Indemnitee has made such request for indemnification. 
  
         5.2 The
Indemnification Request shall set forth Indemnitee’s selection of which of the following forums shall determine whether Indemnitee is entitled to indemnification: 
  
                         (1) A majority vote of a quorum of the Board consisting of Directors who are not parties to the
action with respect to which indemnification is sought. 
  
                         (2) A written opinion of an Independent Counsel (provided that a quorum as set forth in (1)
above does not exist or if such Directors as set forth in (1) above so direct). 
  
                         (3) A majority vote of the stockholders. 
  
                         (4) The court in which the Proceeding is or was pending upon application by Indemnitee. The
Company agrees to bear any and all costs and expenses incurred by Indemnitee or the Company in connection with the determination of Indemnitee’s entitlement to indemnification by any of the above forums. 
  
 6. Presumptions and Effect of Certain Proceedings. No
initial finding by the Board, its counsel, Independent Counsel, arbitrators or the stockholders shall be effective to deprive Indemnitee of the protection of this indemnity, nor shall a court or other forum to which Indemnitee may apply for
enforcement of this indemnity give any weight to any such adverse finding in deciding any issue before it. Upon making a request for indemnification, Indemnitee shall be presumed to be entitled to indemnification under this Agreement and the Company
shall have the burden of proof by clear and convincing evidence to overcome that presumption in reaching any contrary determination. The termination of any Proceeding by judgment, order, settlement, arbitration award or conviction, or upon a plea of
nolo contendere or its equivalent, shall not, of itself, (a) adversely affect the rights of Indemnitee to indemnification except as indemnification may be expressly prohibited under this Agreement, (b) create a presumption that Indemnitee did not
act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the Company or (c) with respect to any criminal action or proceeding, create a presumption that Indemnitee had reasonable cause to
believe that his or her conduct was unlawful. 
  
 7.
Remedies of Indemnitee in Cases of Determination not to Indemnify or to Advance Expenses. 
  
               7.1 In the event that (a) an initial determination is made that Indemnitee is not entitled to indemnification, (b) advances
for Expenses are not made when and as required by this Agreement, (c) payment has not been timely made following a determination of entitlement to indemnification pursuant to this Agreement or (d) Indemnitee otherwise seeks enforcement of this
Agreement, Indemnitee shall be entitled to a final adjudication in a court of competent jurisdiction of his or her entitlement to such indemnification or advance. Alternatively, Indemnitee at his or her option may seek an award in arbitration. If
the parties are unable to 
  

 5 

 agree on an arbitrator, the parties shall provide JAMS (“JAMS”) with a statement of the nature of the dispute
and the desired qualifications of the arbitrator. JAMS will then provide a list of three available arbitrators. Each party may strike one of the names on the list, and the remaining person will serve as the arbitrator. If both parties strike the
same person, JAMS will select the arbitrator from the other two names. The arbitration award shall be made within 90 days following the demand for arbitration. Except as set forth herein, the provisions of Nevada Law shall apply to any such
arbitration. The Company shall not oppose Indemnitee’s right to seek any such adjudication or arbitration award. In any such proceeding or arbitration Indemnitee shall be presumed to be entitled to indemnification under this Agreement and the
Company shall have the burden of proof by clear and convincing evidence to overcome that presumption. 
  
         7.2 An initial determination, in whole or in part, that Indemnitee is not entitled to
indemnification shall create no presumption in any judicial proceeding or arbitration that Indemnitee has not met the applicable standard of conduct for, or is otherwise not entitled to, indemnification. 
  
         7.3 If an initial
determination is made or deemed to have been made pursuant to the terms of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in the absence of (a) a misrepresentation of a material fact
by Indemnitee in the request for indemnification or (b) a specific finding (which has become final) by a court of competent jurisdiction that all or any part of such indemnification is expressly prohibited by law. 
  
         7.4 The Company and
Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, will be inadequate, impracticable and difficult of proof, and further agree that such breach would cause Indemnitee irreparable harm. Accordingly, the
Company and Indemnitee agree that Indemnitee shall be entitled to temporary and permanent injunctive relief to enforce this Agreement without the necessity of proving actual damages or irreparable harm. The Company and Indemnitee further agree that
Indemnitee shall be entitled to such injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without the necessity of posting bond or other undertaking in connection therewith. Any such
requirement of bond or undertaking is hereby waived by the Company, and the Company acknowledges that in the absence of such a waiver, a bond or undertaking may be required by the court. 
  
         7.5 The Company shall be precluded from asserting that the procedures
and presumptions of this Agreement are not valid, binding and enforceable. The Company shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement and is precluded from making any
assertion to the contrary. 
  
         7.6 Expenses incurred by Indemnitee in connection with his or her request for indemnification under, seeking enforcement of, or to recover damages for breach of this Agreement shall be
borne and advanced by the Company. 
  
 8. Other
Rights to Indemnification. Indemnitee’s rights of indemnification and advancement of expenses provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may now or in the future be entitled under
applicable law, the 
  

 6 

 Articles, the Bylaws, an employment agreement, a vote of stockholders or Disinterested Directors, insurance or other
financial arrangements or otherwise. 
  
 9.
Limitations on Indemnification. No indemnification pursuant to Section 3 shall be paid by the Company nor shall Expenses be advanced pursuant to Section 3: 
  
         9.1 Insurance. To the extent that Indemnitee is
reimbursed pursuant to such insurance as may exist for Indemnitee’s benefit. Notwithstanding the availability of such insurance, Indemnitee also may claim indemnification from the Company pursuant to this Agreement by assigning to the Company
any claims under such insurance to the extent Indemnitee is paid by the Company. Indemnitee shall reimburse the Company for any sums he or she receives as indemnification from other sources to the extent of any amount paid to him or her for that
purpose by the Company; 
  
         9.2 Section 16(b). On account and to the extent of any wholly or partially successful claim against Indemnitee for an accounting of profits made from the purchase or sale
by Indemnitee of securities of the Company pursuant to the provisions of Section 16(b) or the Securities Exchange Act of 1934, as amended, and amendments thereto or similar provisions of any federal, state or local statutory law; or 
  
         9.3
Indemnitee’s Proceedings. Except as otherwise provided in this Agreement, in connection with all or any part of a Proceeding which is initiated or maintained by or on behalf of Indemnitee, or any Proceeding by Indemnitee
against the Company or its directors, officers, employees or other agents, unless (a) such indemnification is expressly required to be made by Nevada Law, (b) the Proceeding was authorized by a majority of the Disinterested Directors (c) there has
been a Change of Control or (d) such indemnification is provided by the Company, in its sole discretion, pursuant to the powers vested in the Company under Nevada Law. 
  
 10. Duration and Scope of Agreement; Binding Effect. This Agreement shall continue so long as
Indemnitee shall be subject to any possible Proceeding subject to indemnification by reason of the fact that he or she is or was an Agent and shall be applicable to Proceedings commenced or continued after execution of this Agreement, whether
arising from acts or omissions occurring before or after such execution. This Agreement shall be binding upon the Company and its successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to
all or substantially all of the business or assets of the Company) and shall inure to the benefit of Indemnitee and his or her spouse, assigns, heirs, devisees, executors, administrators and other legal representatives. 
  
 11. Notice by Indemnitee and Defense of Claims.
Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any matter which may be subject to indemnification hereunder,
whether civil, criminal, arbitrative, administrative or investigative; but the omission so to notify the Company will not relieve it from any liability which it may have to Indemnitee if such omission does not actually prejudice the Company’s
rights and, if such omission does prejudice the Company’s rights, it will relieve the Company from liability only to the extent of such prejudice; nor will such omission relieve the Company 
  

 7 

 from any liability which it may have to Indemnitee otherwise than under this Agreement. With respect to any Proceeding:

  
                   (a) The Company will be entitled to participate therein at its own expense; 
  
                   (b) Except as otherwise provided below, to the extent that it may wish, the Company jointly with any other indemnifying party
similarly notified will be entitled to assume the defense thereof, with counsel reasonably satisfactory to Indemnitee. After notice from the Company to Indemnitee of its election so to assume the defense thereof and the assumption of such defense,
the Company will not be liable to Indemnitee under this Agreement for any attorney fees or costs subsequently incurred by Indemnitee in connection with Indemnitee’s defense except as otherwise provided below. Indemnitee shall have the right to
employ his or her counsel in such Proceeding but the fees and expenses of such counsel incurred after notice from the Company of its assumption of the defense thereof and the assumption of such defense shall be at the expense of Indemnitee unless
(i) the employment of counsel by Indemnitee has been authorized by the Company, (ii) Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of the defense of such action
or that the Company’s counsel may not be adequately representing Indemnitee or (iii) the Company shall not in fact have employed counsel to assume the defense of such action, in each of which cases the fees and expenses of counsel shall be at
the expense of the Company; and 
  
                   (c) The Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any
action or claim effected without its written consent. The Company shall not settle any action or claim which would impose any limitation or penalty on Indemnitee without Indemnitee’s written consent. Neither the Company nor Indemnitee will
unreasonably withhold its consent to any proposed settlement. 
  
 11.2 Contribution. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in this Agreement is held by a court of competent jurisdiction to be unavailable to
Indemnitee in whole or part, the Company shall, in such an event, after taking into account, among other things, contributions by other directors and officers of the Company pursuant to indemnification agreements or otherwise, and, in the absence of
personal enrichment, acts of intentional fraud or dishonesty or criminal conduct on the part of Indemnitee, contribute to the payment of Indemnitee’s losses to the extent that, after other contributions are taken into account, such losses
exceed: (i) in the case of a director of the Company or any of its subsidiaries who is not an officer of the Company or any of such subsidiaries, the amount of fees paid to the director for serving as a director during the 12 months preceding the
commencement of the Proceeding; or (ii) in the case of a director of the Company or any of its subsidiaries who is also an officer of the Company or any of such subsidiaries, the amount set forth in clause (i) plus 5% of the aggregate cash
compensation paid to said director for service in such office(s) during the 12 months preceding the commencement of the Proceeding; or (iii) in the case of an officer of the Corporation or any of its subsidiaries, 5% of the aggregate cash
compensation paid to such officer for service in such office(s) during the 12 months preceding the commencement of such Proceeding. 
  

 8 

 12. Period of Limitations. No legal action shall be brought and no cause of action
shall be asserted by or in the right of the Company against Indemnitee, Indemnitee’s estate, spouse, heirs, executors or personal or legal representatives after the expiration of two years from the date of accrual of such cause of action, and
any claim or cause of action of the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal action within such two year period; provided, however, that if any shorter period of limitations is otherwise
applicable to any such cause of action, such shorter period shall govern. 
  
 13. Miscellaneous Provisions. 
  
         13.1 Severability; Partial Indemnity. If any provision or provisions of this Agreement (or any portion thereof) shall be held by a court of
competent jurisdiction to be invalid, illegal or unenforceable for any reason whatever: (a) such provision shall be limited or modified in its application to the minimum extent necessary to avoid the invalidity, illegality or unenforceability of
such provision; (b) the validity, legality and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby; and (c) to the fullest extent possible, the provisions of this Agreement shall be
construed so as to give effect to the intent manifested by the provision (or portion thereof) held invalid, illegal or unenforceable. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a
portion of any Expenses or Liabilities of any type whatsoever incurred by him or her in the investigation, defense, settlement or appeal of a Proceeding but not entitled to all of the total amount thereof, the Company shall nevertheless indemnify
Indemnitee for such total amount except as to the portion thereof for which it has been determined pursuant to Section 5 hereof that Indemnitee is not entitled. 
  
         13.2 Identical Counterparts. This Agreement may be
executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability
is sought needs to be produced to evidence the existence of this Agreement. 
  
         13.3 Interpretation of Agreement. It is understood that the parties hereto intend this Agreement to be interpreted and enforced so as to provide
indemnification to Indemnitee to the fullest extent not now or hereafter prohibited by law. 
  
         13.4 Headings. The headings of the Sections and paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute
part of this Agreement or to affect the construction thereof. 
  
         13.5 Modification and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties to this
Agreement. No waiver of any provision of this Agreement shall be deemed to constitute a waiver of any of the provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver. No waiver of any provision of this
Agreement shall be effective unless executed in writing. 
  

 9 

           13.6 Notices. All
notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if (i) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed
or (ii) mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed: (a) 
  
 If to Indemnitee, to: 
 c/o Axesstel, Inc. 
 6815 Flanders Drive 
 Suite 210 
 San Diego, CA 92121 
 Telephone: (858) 625-2100 
 Telefax: (858) 625-2110 
  
 (b) If to the Company to: 
 c/o Axesstel, Inc. 
 6815 Flanders Drive 
 Suite 210 
 San Diego, CA 92121 
 Telephone: (858) 625-2100 
 Telefax: (858) 625-2110 
 Attention: General Counsel 
  
 or to such other
address as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be. 
  
                   13.7 Governing Law. The parties agree
that this Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Nevada, as applied to contracts between Nevada residents entered into and to be performed entirely within Nevada. 
  
                   13.8 Entire Agreement. This Agreement represents the entire agreement between the parties hereto, and there are
no other agreements, contracts or understanding between the parties hereto with respect to the subject matter of this Agreement, except as specifically referred to herein or as provided in Sections 8 and 2.1 hereof. 
  

 10 

 IN WITNESS WHEREOF, the parties hereto have executed this Indemnification Agreement on the day and year
first above written. 
  

			
	AXESSTEL, INC.
		
	By:	 	 
	Name:	 	 
	Title:	 	 
	
	INDEMNITY
		
	By:	 	 
	Name:	 	 
	Title:	 	 

  

 11Component Supply Agreement

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 Exhibit 10.25 
  
 COMPONENT SUPPLY AGREEMENT 
  
 This Components Supply Agreement (the “Agreement”) is entered into effective as of February 28, 2001 (the “Effective Date”), by and between QUALCOMM CDMA Technologies Asia-Pacific PTE LTD, a
Singapore corporation (“QCTAP”) and Axesstel Incorporated, a California corporation (“Buyer”), with respect to the following facts: 
  
 WHEREAS, QCTAP develops and sells CDMA components and development tools; and 
  
 WHEREAS, Buyer desires to purchase certain components and development tools from time to time and QCTAP desires to sell such components and development tools to Buyer in
accordance with the terns and conditions of this Agreement. 
  
 NOW, THEREFORE,
the parties, in consideration of the mutual promises set forth herein, agree as follows: 
  
 1. DEFINITIONS. The following capitalized terms shall have the meanings set forth below: 
  
 “CDMA” means code division multiple access. 
  
 “Components” means application specific integrated circuits (ASICs), electronic devices, integrated circuits, including firmware thereon and/or families
of devices intended for use in complete fully assembled test equipment, subscriber equipment and/or infrastructure equipment for wireless communications systems. 
  
 “Development Tools” means hardware and software products developed by QCTAP that may be useful in the development of test
equipment, subscriber equipment and/or infrastructure equipment for wireless communication systems including, but not limited to, CDMA Modem Card Reference Boards (known as “SURFs,” and including accompanying QPST software), FFAs, CCAs and
ASIC evaluation boards. 
  
 “License Agreement” means that
certain Subscriber Unit License Agreement between QUALCOMM Incorporated, a Delaware corporation (“QUALCOMM”) and Buyer dated November 14, 2000. 
  
 “Products” means Components and/or Development Tools. 
  
 2. ORDERS. 
  
 a. Purchase Orders. This Agreement shall apply to each and every purchase order (“P.O.”) for Products issued to QCTAP by Buyer
unless the parties expressly agree in writing that this Agreement does not apply. Subject to the following sentence, each P.O. accepted by QCTAP, together with this Agreement, shall constitute the entire agreement between Buyer and QCTAP with
respect to the purchase, sale and delivery of the Products described in such P.O. Any terms or conditions stated in any P.O., acknowledgment or invoice (except for details of 
  

 1 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 price, quantity, delivery schedule and other details of delivery which are not inconsistent with the terms of this Agreement) shall be of no force and effect, and no
course of dealing, usage of trade, or course of performance shall be relevant to explain or modify any term expressed in the Agreement. This Agreement, together with all exhibits attached hereto, which are incorporated herein by this reference,
constitutes the entire agreement between the parties and supersedes all prior negotiations, representations and agreements between the parties with respect to the subject matter hereof. No modification, variation, or amendment of this Agreement
shall be effective unless made in writing and signed by both parties to this Agreement. 
  
 b. Procedures. From time to time during the term of this Agreement. Buyer may order quantities of Products from QCTAP by submitting to QCTAP, Attn.: Sales Administration, at least the number of days in
advance of the required “Lead Time,” a written P.O. stating the items and quantities of Products which Buyer desires to purchase from QCTAP and the requested delivery dates for such item. As permitted below, Buyer may also request
adjustments to the delivery dates in a previously accepted P.O. by submitting a new P.O. (a “Modified P.O.”) specifying the requested changes. QCTAP shall accept any P.O. issued by Buyer within the scope of the most recent forecast
submitted to QCTAP pursuant to Section 3 below and in conformance with the terms of this Agreement, including the provision of adequate Lead Times. Lead Times are estimates and are subject to change, except with respect to any P.O. previously
accepted by QCTAP. Unless canceled or deferred as permitted below (via a Modified P.O.), Buyer shall be obligated to purchase the quantities of Products on the schedule specified in any P.O. accepted by QCTAP. QCTAP shall acknowledge in writing each
P.O. within ten (10) business days of receipt, and such P.O. shall be deemed accepted by QCTAP unless, within twenty (20) days of receipt of such P.O., QCTAP submits to Buyer, in writing, an objection to the P.O. based upon the failure of Buyer to
comply with this Agreement in submitting the P.O. (including, without Imitation, the obligation to submit monthly rolling forecasts in accordance with Section 3 below). If QCTAP so objects to any P.O., such P.O. shall not be binding on either party
until a compliant P.O. is submitted by Buyer to QCTAP. A P.O. becomes a part of this agreement in accordance with this Section 2 only after it is accepted in writing by QCTAP or is deemed accepted in accordance with the above provisions. 

 
 c. Reschedule/Cancellation. Buyer and QCTAP acknowledge that
substantial lead-times are involved in the manufacture and delivery of certain Components and that QCTAP would likely suffer significant loss in the event that Buyer seeks to cancel an order for Components within such lead-times. In recognition of
these factors, any initial P.O. for Components accepted by QCTAP shall be subject to the terms regarding cancellation or deferral of delivery of Components by Buyer set forth on Exhibit A hereto. 
  
 3. COMPONENT FORECASTS. To facilitate planning for Component manufacture and
delivery, Buyer further agrees to supply, beginning with Buyer’s first P.O. for Components, a 12 month rolling forecast of Buyer’s monthly Component requirements and written monthly updates thereof on the first day of each month
thereafter. Buyer’s obligation to provide the above rolling forecast shall be ongoing such that QCTAP shall be periodically apprised of Buyer’s estimated requirements for any succeeding 12 month period. [***] QCTAP shall promptly notify
Buyer if QCTAP believes that it is unlikely to be able to supply Buyer’s forecasted requirements. 
  

 2 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 If during the term of this Agreement QCTAP decides permanently to cease manufacturing and offering to sell to Buyer any Component previously purchased by Buyer during the
term of this Agreement (a “Discontinued Component”), then, as long as Buyer is not in breach of this Agreement, QCTAP will (i) notify Buyer in writing [***] prior to the date that such Component will become a Discontinued Component and
(ii) provide Buyer with the opportunity to make a final bulk purchase of the Discontinued Component. 
  
 4. DELIVERY. For all Products designated by QCTAP for delivery from QCTAP’s facilities in Singapore, deliveries shall be made [***]. For all Products designated by QCTAP for delivery from shipping
points outside of Singapore, deliveries shall be made [***]. The Buyer is responsible for obtaining at its own risk and expense any import license or other official authorization for the importation of the goods at the agreed point of destination.
The Buyer is responsible for customs clearance at the agreed place of destination, and the Buyer shall bear all duties, taxes and other official charges payable upon importation of the goods as well as any and all costs and risks of carrying out
customs formalities. If shipment of any Product is delayed at Buyer’s request, Buyer shall bear all reasonable and necessary transportation and/or storage related costs of holding such Product, and QCTAP may invoice Buyer for such product on
the date when QCTAP is prepared to make shipment. 
  
 5. TITLE AND RISK
OF LOSS. Title and risk of loss or damage to the Products shall pass from QCTAP to Buyer when [***]. 
  
 6. INSPECTION; ACCEPTANCE. Buyer shall inspect and may reject all Products that are defective within [***]. If Buyer fails to effectively reject any Products in a written document delivered to QCTAP
within such [***] period, Buyer shall be deemed conclusively to have accepted such Products. This provision shall in no way impair Buyer’s rights under the warranty set forth in Section 9 of this Agreement with respect to latent or other
defects which would not have been readily ascertainable upon inspection of the Products within such [***] period. 
  
 7. PRICE AND PAYMENT TERMS. The prices of the Products delivered shall be mutually agreed upon by QCTAP and Buyer. All amounts stated herein and/or required
to be paid hereunder are stated in, and shall be paid in, U.S. Dollars. The prices do not include any applicable sales, use, value-added, excise and/or withholding taxes; customs duties; fees; or import fees. [***] 
  
 QCTAP will invoice Buyer for Products purchased upon delivery of such Products to the [***],
and Buyer shall pay all such invoices by check or wire transfer within [***] after the invoice date. QCTAP reserves the right to require reasonable assurances of payment by Buyer (for example, the issuance via letter of credit from a reputable bank
provided by Buyer to QCTAP not later than [***] prior to the scheduled delivery date). QCTAP may, from time to time, evaluate Buyer’s credit standing and, on that basis, establish a credit limit to accommodate Buyer’s issuance of P.O.s as
herein provided. Buyer shall provide any reasonable assistance requested by QCTAP to make such evaluation. 
  
 Regardless of what payment terms apply to any P.O., Buyer shall pay to QCTAP a late charge on any past due amounts at the rate of [***] or the maximum amount permitted by law, [***]. 
  

 3 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 [***] Such agreement shall be without prejudice so Buyer’s right to pursue any claim or remedy except as an offset against any payment owed by Buyer under this
Agreement. 
  
 8. SOFTWARE. Products sold to Buyer hereunder may
contain software or firmware (“Software”), and, except as otherwise expressly provided herein, all references to “Products” in this Section 8 shall be deemed to include such Software, provided that nothing herein shall be
construed as the sale of any Software to Buyer. QCTAP hereby grants to Buyer a non-exclusive license to use the Software solely in conjunction with the Products sold by QCTAP for which QCTAP intends it to be used, for the duration of the useful life
of such Products and subject to the terms and conditions of this Agreement. Buyer shall not, without the prior written consent of QCTAP, (i) alter, modify, translate, or adapt any Software or create any derivative works based thereon; (ii) copy any
Software; (iii) assign, sublicense or otherwise transfer the Software in whole or in part, except in conjunction with the resale or other transfer to a third party of a product in which such the Product containing such Software is contained; (iv)
use the Software except as specifically contemplated in this Agreement; or (v) disclose the Software to any third party. The entire right, title and interest in the Software shall remain with QCTAP and its affiliates, and Buyer shall not remove any
copyright notices or other legends from the Software or any accompanying documentation. Nothing herein shall be deemed to grant any rights to Buyer under any of QCTAP’s or affiliates’ patents (such rights, if any, being granted only under
the terms of the License Agreement). 
  
 9. WARRANTIES. 

 
 a. Warranty. [***] 
  
 b. Remedy/Disclaimer. Buyer’s sole remedy for breach of
any of the above warranties shall be the return of the allegedly defective Product to QCTAP [***]. Buyer shall obtain from QCTAP a written authorization (RMA) before returning any allegedly defective Product. If such Product is defective, QCTAP, at
QCTAP’s sole option, shall repair or replace such Product within thirty (30) business days of QCTAP’s receipt thereof or, if QCTAP determines that it is unable to repair or replace such Product, QCTAP shall refund to Buyer the purchase
price paid for such defective Product. Notwithstanding the foregoing, no warranty, expressed or implied, shall extend to any Product which has been subjected to misuse, neglect, accident, or improper storage or installation or which has been
repaired, modified, or altered by anyone other than QCTAP. Buyer hereby acknowledges and agrees that it has not relied on any representations or warranties other than those expressly set forth herein. QCTAP MAKES NO OTHER WARRANTIES, EXPRESS OR
IMPLIED, WITH RESPECT TO THE PRODUCT OR THE SOFTWARE, INCLUDING BUT NOT LIMITED TO ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR AGAINST INFRINGEMENT, OR ANY EXPRESS OR IMPLIED WARRANTY ARISING OUT OF TRADE USAGE OR OUT OF A
COURSE OF DEALING OR COURSE OF PERFORMANCE. 
  
 10. INDEMNIFICATION.
Buyer shall indemnify, defend and hold harmless QCTAP and its affiliates against any and all losses, claims, damages and expenses (including attorneys’ fees) arising out of or related to Buyer’s (including its employees’, affiliates
and independent contractors), misuse and/or modification of the Product, or Buyer’s (or any of its affiliate’s) use 
  

 4 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 of any Product in combination with any other items, whether or not furnished by QCTAP or any of its affiliates, unless such use is the necessary, inherent and/or intended
use of the Product. QCTAP shall provide Buyer with prompt notice of any claim within the foregoing provision, shall give Buyer the full right to defend any such claim and shall cooperate fully in such defense. 
  
 [***] 
  
 11. INTELLECTUAL PROPERTY. The sale of Products to Buyer does not convey to Buyer any intellectual property rights in such
Products, including but not limited to any rights under any patent, trademark, copyright, or trade secret. Except as expressly provided in Section 8 of this Agreement, Buyer may not use or sell any Product, alone or in combination with other
software or components, without a separate license from QCTAP under all applicable patents, copyrights and trademarks. Buyer’s use and sale of any Products shall be solely in accordance with the terms and conditions of the License Agreement and
this Agreement, and the incorporation of Components purchased from QCTAP into Buyer’s products shall not relieve Buyer of any obligation under the License Agreement to pay royalties. This Agreement shall not modify or abrogate Buyer’s
obligations under the License Agreement, including but not limited to Buyer’s obligation to pay all royalties specified thereunder, and shall not expand or alter Buyer’s rights thereunder. Neither the sale of any Product nor any provision
of this Agreement shall be construed to grant to Buyer, either expressly, by implication or by way of estoppel, any license under any patents or other intellectual property rights of QCTAP or any of its affiliates covering or relating to any other
product or invention or any combination of Products with any other product Buyer shall use the Products furnished by QCTAP solely in accordance with the terms of this Agreement, and Buyer shall not, directly or indirectly, disassemble, decompile,
reverse engineer, or analyze the physical construction of any of the Products for any purpose. 
  
 To the extent that Buyer has a royalty-free license under any third party’s intellectual property rights, if any, applicable to a Product which license permits Buyer to have such Product made for Buyer, Buyer
acknowledges that it is exercising such “have made” rights as to all purchases of such Product from QCTAP under this Agreement. If the License Agreement or any other agreement between QCTAP and Buyer would otherwise obligate QCTAP to pay
royalties to Buyer in connection with the manufacture, use, sale or import of any Product, no such royalties shall be payable on any Product sold to Buyer. 
  
 12. REPRESENTATION REGARDING USE. Buyer hereby represents and warrants to QCTAP that any Product being purchased by Buyer hereunder will be used by Buyer
solely to develop and manufacture subscriber equipment, infrastructure equipment or test equipment, as the case may be, for wireless communications systems for sale subject to and in accordance with the License Agreement, including the payment of
the royalty contained therein. Buyer shall not resell any Product provided, however, that Buyer may resell the Components as part of and included within the complete subscriber equipment, infrastructure equipment or test equipment. as the case may
be, sold by Buyer in accordance with the terms and conditions of the License Agreement. 
  
 13. TERM AND TERMINATION. The term of this Agreement shall commence upon she Effective Date and shall remain in effect for a period of five (5) years and shall apply to all P.O.s for the purchase, sale and delivery of Products
during that period. Thereafter, the Agreement 
  

 5 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 shall be automatically extended on a year-to-year basis unless terminated by either party in writing on not less than sixty (60) days prior written notice to the other
party prior to the applicable anniversary of the Effective Date. Each party shall have the right to terminate this Agreement and/or to cancel or hold any and/or all orders placed by Buyer and any and/or all shipments of Products, regardless of any
prior confirmation or acceptance by QCTAP, and without liability of any kind if: (a) the other party is or becomes insolvent; (b) the other party makes an assignment for the benefit of creditors, or a receiver is appointed to take charge of all or
any past of Buyer’s assets or business; (c) the other party is the subject of a bankruptcy or reorganization proceeding, whether voluntary or involuntary; or (d) the other party fails to timely perform any of its obligations under the Agreement
and such failure is not cured within thirty (30) days after written notice of such failure. In addition, QCTAP may terminate this Agreement if Buyer is in default under the License Agreement and such default is not cured within the cure period
specified therein. 
  
 14. LIMITATION OF LIABILITY. [***]

  
 15. RESTRICTIONS ON DISCLOSURE AND USE OF INFORMATION.

  
 a. Restrictions on Disclosure and Use. All
documentation and technical and business information and intellectual property in whatever form recorded that a party does not wish to disclose without restriction (“Information”) shall remain the property of the furnishing party and may
be used by the receiving party only as follows. Such Information (a) shall not be reproduced or copied, in whole or part, except for use as expressly authorized in this Agreement; (b) shall, together with any full or partial copies thereof, be
returned or destroyed when no longer needed or upon any termination or expiration of this Agreement; and (c) shall be disclosed only to employees or agents of the receiving party who have a need to know. Moreover, such Information shall be used by
the receiving party only for the purpose of performing under this Agreement or in the exercise of any rights it may receive under this Agreement. Unless the furnishing party consents in this Agreement or otherwise in writing, such Information shall
be held in strict confidence by the receiving party. The receiving party may disclose such Information to other persons, upon the furnishing party’s prior written authorization, but solely to perform acts which this clause expressly authorizes
the receiving party to perform itself and further provided such other person agrees in writing (a copy of which writing will be provided to the furnishing party at its request) to the same conditions respecting use of Information contained in this
clause and to any other reasonable conditions requested by the furnishing party. 
  
 These restrictions on the use or disclosure of Information shall not apply to any Information: (i) which can be proven to be or have been independently developed by the receiving party; or (ii) after it has become generally available to the
public without breach of this Agreement by the receiving party; or (iii) which at the time of disclosure to the receiving party was known to such party free of restriction and clearly evidenced by documentation in such party’s possession; or
(iv) which the furnishing party agrees in writing is free of such restrictions; or (v) which is disclosed in response to a valid legal order of a competent court of law or other order; provided, however, that the receiving party shall first notify
the disclosing party in writing of such order and permit the disclosing party to seek an appropriate protective order to ensure that the information being disclosed remains protected as confidential. The provisions of this Section 15 
  

 6 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 shall be effective for a period of fifteen (15) years after the date of the last disclosure made under this Agreement. 
  
 b. Scope of Information. Information delivered in tangible form
is subject to this Section 15 if it has been identified or marked as confidential or otherwise subject to this Section 15. Information which is delivered orally is subject to this Section 15 without regard to whether it has been identified as
confidential or subject to this Section 15. Each party agrees to use reasonable efforts to make or otherwise identify as proprietary or confidential all Information that it desires to be subject to the terms of this Section 15 before furnishing it
to the other party, and upon request, a party shall promptly identify whether specified information must be held by the requesting party subject to this clause. Information which is delivered orally may be summarized in writing by the disclosing
party and delivered to the receiving party within (45) days after disclosure thereof. 
  
 16. ASSIGNMENT. Buyer shall not assign this Agreement or any right or interest under this Agreement or delegate any obligation to be performed under this Agreement without QCTAP’s prior written consent, which consent
shall not be unreasonably withheld. QCTAP shall not assign this Agreement or any right or interest under this Agreement or delegate any obligation to be performed under this Agreement except to a majority owned or controlled affiliate of QCTAP, or
to a third party upon Buyer’s written consent, which shall not be unreasonably withheld: provided, however, in the event that QCTAP sells, transfers or otherwise disposes of all or substantially all of its assets relating to the design,
manufacture and sale of Components, then QCTAP shall be entitled, without obtaining Buyer’s prior written consent, to assign this Agreement and any related rights or interests wider this Agreement to any such successor-in-interest(s) to such
assets. Any attempted assignment in contravention of this Section 16 shall be void. 
  
 17. APPLICABLE LAW. The Agreement shall be governed by the laws of the State of California, excluding the U.N. Convention on International Sale of Goods, and without regard to conflict of laws principles. All disputes arising
in connection therewith shall be heard only by a court of competent jurisdiction in San Diego County, California, and the prevailing party in any legal proceeding shall be entitled to recover its reasonable attorneys’ fees incurred in
connection therewith. 
  
 18. FORCE MAJEURE. Neither party shall be
in default or liable for any loss or damage resulting from delays in performance or from failure to perform or comply with terms of this Agreement due to any causes beyond its reasonable control, which causes include but are not limited to Acts of
God or the public enemy; riots and insurrections war; fire; strikes and other labor difficulties (whether or not the party is in a position to concede to such demands); embargoes; judicial action; lack of or inability to obtain necessary labor,
materials, energy, components or machinery; and acts of civil or military authorities. 
  
 19. NOTICES. All notices, requests, demands, consents, agreements and other communications required or permitted to be given under this Agreement shall be in writing and shall be mailed to the party to whom notice is to be
given, by first class mail, postage prepaid, or sent by facsimile or electronically and confirmed, properly addressed as follows (in which case 
  

 7 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 such notice shall be deemed to have been duly given on the day the notice is first received by the party): 
  

					
	 QCTAP
	  	 	  	QUALCOMM CDMA Technologies Asia-Pacific PTE LTD
	 	  	 	  	QUALCOMM Incorporated
	 	  	 	  	5775 Morehouse Drive
	 	  	 	  	San Diego, California 92121 U.S.A.
	 	  	 	  	Facsimile: (858) 658-1587
	 	  	 	  	Ann.: President, QUALCOMM CDMA Technologies

  
 With a Copy at the same address to:

  

			
	 	    	General Counsel
	 	    	Facsimile: (858) 658-2500
	 	    	 
	 BUYER:
	    	Axesstel Incorporated
	 	    	2nd Floor, Chosum Naewha Bldg.
	 	    	Suane 4-1 Doug, Bundang-Gu
	 	    	Sungnam-City, Kyunggi-Do
	 	    	463-020, Korea
	 	    	Facsimile: 2-31-716-1894
	 	    	Attn.: Mr. Soo-Hyun Park, Director

  
 With a Copy to: 
  

			
	 	  	 Axesstel Incorporated

	 	  	 6480 Weathers Place, Suite 300

	 	  	 San Diego, CA 92121

	 	  	 Facsimile: (858) 625-2110

	 	  	 Aim.: Mike Kwon, President & CEO

  
 The above addresses can be changed by
providing notice to the other party in accordance with this Section. 
  
 20.
MISCELLANEOUS PROVISIONS. No addition to or modification of the Agreement shall be effective unless made in writing and signed by the respective representatives of QCTAP and Buyer. Any delay or failure to enforce at any time any provision
of the Agreement shall nor constitute a waiver of the right thereafter to enforce each and every provision thereof. If any of the provisions of the Agreement is determined to be invalid, illegal, or otherwise unenforceable, the remaining provisions
shall remain in full force and effect. The parties’ rights and obligations Which by their sense amid context are intended to survive any termination or expiration of this Agreement shall so survive, including but not limited to Sections
8,9,10,11,12,14,15 and 17 hereof. 
  

 8 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first set forth above. 
  
  

									
	 QUALCOMM CDMA Technologies
	 	 	 	Axesstel Incorporated
	 Asia-Pacific PIE LTD
	 	 	 	 
	 	 	 	 	 
					
	By:	 	/s/ William E. Cheney	 	 	 	By:	 	/s/ H. John Chough
	 	 	WILLIAM E. CHENEY	 	 	 	 	 	 H. JOHN CHOUGH
  

					
	Title:	 	VP, Finance	 	 	 	Title:	 	Director of Finance & Operation
	 	 	QUALCOMM CDMA Technologies	 	 	 	 	 	 

  

 9 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 EXHIBIT A 
  
 RESCHEDULE AND CANCELLATION TERMS 
  
 [***] 
  

 10 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 Amendment to Component Supply Agreement 
  
 This Amendment to Component Supply Agreement (the “Amendment”) is entered into as of February 3, 2004 (the “Amendment Effective
Date’), by and between QUALCOMM CDMA Technologies Asia-Pacific PTE LTD (“QCTAP”), a Singapore corporation, and Axesstel Incorporated, a California corporation (“Buyer”), who hereby agree to amend that certain Component
Supply Agreement entered into between QCTAP and Buyer dated February 28, 2001 (the “CSA”) as follows: 
  
 1. Buyer’s Agent. A new Section 21, “Buyer’s Agent”, is hereby added to the CSA as follows: 
  
 21. “BUYER’S AGENT. 
  
 a. Appointment. For the purpose of this Agreement, Buyer may
designate and appoint another entity as Buyer’s agent, having the authority to perform the following duties only on Buyer’s behalf, pursuant to, and subject to the limitations of, this Agreement upon QCTAP’s consent to appointment of
such agent, such consent not to be unreasonably withheld (hereinafter “Agent”): 
  

	 	i.	To place POs and Forecasts hereunder (hereinafter “Agent POs” and “Agent Forecasts,” respectively); 

  

	 	ii.	To receive invoices hereunder; 

  

	 	iii.	To receive and inspect Products hereunder; 

  

	 	iv.	To make payments due QCTAP hereunder; 

  

	 	v.	To coordinate and execute all procedures for the return of any defective Product sold hereunder; 

  

	 	vi.	To confirm and follow-up deliveries hereunder; and 

  

	 	vii.	For any other such activity or role which QCTAP and Buyer approve in writing in the course of performing the Agreement. 

  
 QCTAP shall accept receipt of Agent Forecasts and Agent POs subject to the terms and
conditions of this Agreement (but only to the extent QCTAP would be obligated to accept the same from Buyer), provided that (i) Buyer shall be solely responsible for transmitting directly to QCTAP all such Agent Forecasts and Agent POs and QCTAP
shall be entitled to ignore all Agent Forecasts and Agent POs not submitted directly by Buyer to QCTAP; (ii) such Agent POs shall be in lieu of POs from Buyer (to the extent of forecasted volumes); (iii) the form of all Agent POs shall be in
accordance with the terms and conditions of this Agreement; and (iv) Buyer shall coordinate all issues regarding Agent Forecasts and Agent POs. 
  
 b. Terms and Conditions. Each Agent shall be bound by and subject to the obligations, limitations and restrictions set forth in this
Agreement. Each Agent PO will be 
  

 1 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 deemed to incorporate all the terms, conditions and provisions of this Agreement. Notwithstanding anything herein contained to the contrary, Agents will not be deemed
third party beneficiaries to this Agreement, and only Buyer shall have the right and/or ability to enforce any rights hereunder against QCTAP. 
  
 c. Guaranty. In order to induce QCTAP to accept Agent POs, Buyer hereby unconditionally and irrevocably guarantees the prompt and complete
performance and payment of all obligations of the Agents under this Agreement. If any Agent fails to perform any of its obligations in accordance with this Agreement, Buyer shall immediately pay for all amounts due from any such Agent and otherwise
perform all of such Agent’s obligations under this Agreement. The guaranty set forth in this Section is absolute and unconditional. This is an absolute guaranty of payment and performance and not a guaranty of collection. The obligations
hereunder are independent of the obligations of any Agent, and a separate action or actions may be brought against Buyer whether or not action is brought against any such Agent or whether or not any such Agent may be joined in any such action. With
respect to this Section 21 (Buyer’s Agent), Buyer waives any right to require QCTAP to (a) proceed against any Agent or other person; or (b) pursue any other remedy in QCTAP’s power whatsoever. The liability of Buyer under this Section
shall not be deemed to be waived, released, discharged, impaired or effected by any alteration, amendment, acceleration, extension, modification, waiver or change of the amount of time or manner of payment or performance of any of the obligations of
any Agent. Buyer waives any defense of any Agent or by reason of the cessation from any cause whatsoever of the liability of any such Agent. Buyer waives any setoff, defense or counterclaim that any Agent may have against QCTAP. Buyer waives any
defense arising out of the absence, impairment or loss of any right of reimbursement or subrogation or any other rights against any Agent. Buyer waives all presentments, demands for performance, notices of nonperformance, protests, notices of
protest, notices of dishonor, and notices of acceptance of the guaranty set forth in this Section and of the existence, creation, or incurring of new or additional indebtedness. 
  
 QCTAP shall have the right to insist on and receive reasonable assurance of payment from any Agent in the manner as provided in Section 7;
and all Agent’s POs must be in accordance with the terms and conditions of this Agreement. In addition, each Agent PO must contain the following language: 
  

“This purchase order is being submitted in accordance with the terms and conditions of that certain Component Supply Agreement, dated
February 28, 2001, between QUALCOMM CDMA Technologies Asia-Pacific PTE LTD and Axesstel Incorporated, and the undersigned hereby agrees to be bound by the terms and conditions of said agreement.” 
  
 c. Appointment of Wistron Neweb Corporation. Buyer hereby designates
and appoints Wistron Neweb Corporation, a Taiwan corporation having offices at 4-6F, No. 10-1, Lihsin Road 1, Science-based Industrial Park, Hsinchu 300, Taiwan, R.O.C, as an Agent hereunder and QCTAP hereby consents to such appointment. 

 
 d. Additional Agents. Buyer will notify QCTAP in writing of
its intent to designate and appoint additional Agents.” 
  

 2 

 Confidential Portions of this Document Have Been 
 Redacted and Filed Separately with the Commission 
  
 2. No Other Amendment or Modification. Except as expressly set forth in this Amendment, the Component Supply Agreement remains in full force and effect
without modification. The terms and conditions of this Amendment and the Component Supply Agreement shall not be modified or amended except by a writing signed by authorized representatives of both Parties. 
  
 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be effective as of the
date first set forth above. 
  

									
	 QUALCOMM CDMA Technologies
 Asia-Pacific PTE LTD
	 	 	 	Axesstel Incorporated
	 	 	 	 	 
					
	By:	 	 /s/ James P. Lederer
	 	 	 	By:	 	/s/ David Morash
	 	 	 	 	 	 	 	 	 
					
	Title:	 	 VP, Finance, QCT
	 	 	 	Title:	 	COO
	 	 	 	 	 	 	 	 	 

  

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00073-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00073-of-00352.parquet"}]]